Therefore, in the present study, we aimed to investigate the clinical significance of EGFR-TKIs as an anticancer drug candidate and to elucidate the molecular mechanism underlying its anticancer activity in human oral cancer. This evidence concerns the gene EGFR and lip and oral cavity carcinoma.